Cav3.1 Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Introduction
Cav3.1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes. [@huguenard2002]
Protein Overview
Cav3.1 is the α1G subunit of voltage-gated calcium channels, forming the pore of the T-type (low-voltage activated) calcium channel. It is encoded by the CACNA1G gene. [@chen2013]
Basic Information
Structure
Cav3.1 has the typical structure of T-type calcium channel α1 subunits:
24 transmembrane segments in 4 homologous domains
Voltage sensor (S1-S4) with unique gating properties
Pore loop (P-loop) with selectivity filter
Intracellular N-terminus and C-terminus
S3-S4 linker shorter than high-voltage activated channels
Key structural differences from high-voltage activated channels:
Lower voltage sensitivity due to different S4 charges
Cav3.1 Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Background
The study of Cav3.1 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References
[Wu J, et al, Nature 2020;585:e5 (2020)](https://pubmed.ncbi.nlm.nih.gov/33268865/)
[Huguenard JR, et al, Annu Rev Physiol 2002;64:159-187 (2002)](https://pubmed.ncbi.nlm.nih.gov/11830674/)
[Chen Y, et al, Ann Neurol 2013;74:423-431 (2013)](https://pubmed.ncbi.nlm.nih.gov/23780923/)
[Coutelier M, et al, Brain 2015;138:3163-3177 (2015)](https://pubmed.ncbi.nlm.nih.gov/26637561/)
[Hwang J, et al, Brain 2019;142:2086-2101 (2019)](https://pubmed.ncbi.nlm.nih.gov/31219789/)
[Cain SM, et al, Channels 2017;11:305-323 (2017)](https://pubmed.ncbi.nlm.nih.gov/28473962/)
[Powell KL, et al, Brain 2014;137:2130-2140 (2014)](https://pubmed.ncbi.nlm.nih.gov/24736303/)
[Kim D, et al, J Neurosci 2001;21:3064-3072 (2001)](https://pubmed.ncbi.nlm.nih.gov/11306631/)